Does renal haemangioblastoma exist? Evidence for inclusion within the MTOR ‐associated renal cell carcinoma with fibromyomatous stroma spectrum
- 8 July 2026
- journal article
- editorial
- Published by Wiley in Histopathology
- Vol. 89 (4) , 571-573
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entityVirchows Archiv, 2025
- Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutationsHistopathology, 2025
- Renal haemangioblastoma: a clinicopathologic and molecular characterization of 8 cases supporting the presence of recurrent MTOR pathway alterationsHistopathology, 2025
- Renal cell carcinoma with fibromyomatous stroma (RCC FMS) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complexHistopathology, 2025
- PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosisHuman Pathology, 2013